Calculus Capital Limited / Stargrove Pictures Limited UK Creative Content EIS Fund

Hardman & Co

Why invest

Positives

  • Strategy: To invest in a portfolio of unquoted media companies that will generate meaningful IP.

Issues

  • Time to invest: The target time to invest of 15 months is longer than for some other EIS funds.

The Investment Manager

Positives

  • Team: One of the longest standing managers in the VCT/EIS area, Calculus has a highly experienced and stable team.

Issues

  • Past performance: While Calculus has a substantial and credible record from investing in other sectors, this is a new area for the team. However, the addition of Stargrove brings sector experience.

Nuts & bolts

  • Offer period: Closing dates are quarterly on last Fridays of October, January, April and June.
  • Diversification: The aim is to invest in at least six companies.
  • Valuation: Investors will receive valuations twice a year. Industry guidelines will be used, with two auditors examining the figures.

Specific issues

  • Fees: Mixture of direct fees and charged via the investee companies.
  • Performance fee: 20% on gains over a hurdle rate of 1.2x total capital invested.

Risks

  • Risk mitigation: Although a new sector for the Manager, Calculus will use its established investment processes and has brought in a specialist advisor in Stargrove.
  • Target return: Overall, the strategy is medium-risk relative to other EIS/VCT products, with the target capital return of 2.0x towards the top end of what we’d expect for that risk category.

DOWNLOAD THE FULL REPORT

Share on:

Latest Company News

Thor Energy moves HY-Range towards drilling with seismic work fully funded

Thor Energy is funding the next stage of HY-Range internally as seismic work tests whether strong surface hydrogen readings can be converted into credible drilling targets.

Record sets November opening for 2027 internship applications

Record Plc will open applications for its 2027 internship programme in November as the company brings its 2026 summer intake to a close.

Genflow Biosciences comes into focus as pet longevity demand grows

Genflow Biosciences moves into sharper focus as pet longevity shifts towards evidence, prevention and healthier ageing.

Paladin shifts focus to Canadian uranium growth

Paladin Energy is shifting its focus from the completed Langer Heinrich ramp-up to advancing Patterson Lake South as its next major uranium growth project.

Verizon expands Google partnership across AI, fibre and customer offers

Verizon is expanding its Google partnership across AI, fibre infrastructure and customer offers as it looks to improve efficiency, retention and revenue growth.

Ilika targets medical device opportunities with Stereax at MedTech Ireland

Ilika’s Stereax technology will be presented at MedTech Ireland 2026 as the company targets further opportunities in active implanted medical devices.

    Search